There has been a recent nationwide shortage of ADHD medication due to increased global demand and manufacturing problems.
The problem is ongoing via the NHS, although some medications are now in stock certain supplies remain disrupted.
The charity ADHD UK recently reported that Takeda, a major supplier of ADHD medication, expects ‘intermittent disruption’ until April 2024. We would recommend you speak to your GP or our assessment team for more information.
Alternative medication may be available until manufacturers resolve the supply issue.
ADHD medication is evolving as research into ADHD continues. Some of the new developments for ADHD medication next year could include:
- The development of more targeted and effective medications with fewer side effects.
- Longer-lasting formulations or alternative administration methods (e.g., patches or extended-release options) that enhance treatment adherence.
- More targeted and personalised treatments
We will report on any advancements to medication announced in 2024.